Global Blood Therapeutics, Inc.

DB:G5B 주식 보고서

시가총액: €4.7b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Global Blood Therapeutics 관리

관리 기준 확인 3/4

주요 정보

Ted Love

최고 경영자

US$8.2m

총 보상

CEO 급여 비율8.7%
CEO 임기8.3yrs
CEO 소유권1.4%
경영진 평균 재임 기간6.5yrs
이사회 평균 재임 기간5.8yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Ted Love 의 보수는 Global Blood Therapeutics 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2022n/an/a

-US$322m

Mar 31 2022n/an/a

-US$310m

Dec 31 2021US$8mUS$716k

-US$303m

Sep 30 2021n/an/a

-US$277m

Jun 30 2021n/an/a

-US$266m

Mar 31 2021n/an/a

-US$249m

Dec 31 2020US$18mUS$661k

-US$248m

Sep 30 2020n/an/a

-US$282m

Jun 30 2020n/an/a

-US$286m

Mar 31 2020n/an/a

-US$291m

Dec 31 2019US$10mUS$597k

-US$267m

Sep 30 2019n/an/a

-US$220m

Jun 30 2019n/an/a

-US$199m

Mar 31 2019n/an/a

-US$182m

Dec 31 2018US$10mUS$569k

-US$174m

Sep 30 2018n/an/a

-US$166m

Jun 30 2018n/an/a

-US$152m

Mar 31 2018n/an/a

-US$135m

Dec 31 2017US$8mUS$520k

-US$117m

Sep 30 2017n/an/a

-US$103m

Jun 30 2017n/an/a

-US$95m

Mar 31 2017n/an/a

-US$89m

Dec 31 2016US$1mUS$479k

-US$82m

Sep 30 2016n/an/a

-US$71m

Jun 30 2016n/an/a

-US$65m

Mar 31 2016n/an/a

-US$58m

Dec 31 2015US$2mUS$438k

-US$51m

보상 대 시장: Ted's total compensation ($USD8.19M) is above average for companies of similar size in the German market ($USD2.68M).

보상과 수익: Ted's compensation has been consistent with company performance over the past year.

CEO

Ted Love (63 yo)

8.3yrs

테뉴어

US$8,193,309

보상

Dr. Ted W. Love, M.D., serves as Independent Director at Royalty Pharma plc since July 30, 2020. He serves as Director of Seagen Inc. (formerly known as Seattle Genetics, Inc.). since August 2020. He serve...

리더십 팀

이름위치테뉴어보상소유권
Ted Love
President8.3yrsUS$8.19m1.37%
$ 64.1m
Jeffrey Farrow
CFO & Principal Accounting Officer6.5yrsUS$2.76m0.040%
$ 1.9m
Jung Choi
Chief Business & Strategy Officer7.5yrsUS$2.73m0.37%
$ 17.5m
David Johnson
Chief Commercial Officer4.6yrsUS$2.75m0.084%
$ 3.9m
Kim Smith-Whitley
Executive VP and Head of Research & Development1.4yrsUS$2.98m0.0089%
$ 415.3k
David Phillips
Founder & Advisor11.8yrs데이터 없음데이터 없음
Matthew Jacobson
Founder & Advisor11.8yrs데이터 없음데이터 없음
Andrej Sali
Founder & Advisor11.8yrs데이터 없음데이터 없음
Nazila Habibizad
Executive Vice President of Operations2.5yrs데이터 없음0.062%
$ 2.9m
Stephanie Yao
Senior Director of Corporate Communications & Investor Relationsno data데이터 없음데이터 없음
Patricia Suvari
Chief Legal Officer & Secretary6yrsUS$5.93m0.064%
$ 3.0m
Steven Immergut
Senior VP & Head of Corporate Communications3.8yrs데이터 없음데이터 없음

6.5yrs

평균 재임 기간

60yo

평균 연령

경험이 풍부한 관리: G5B's management team is seasoned and experienced (6.5 years average tenure).

이사회 구성원

이름위치테뉴어보상소유권
Ted Love
President9.1yrsUS$8.19m1.37%
$ 64.1m
Mark Perry
Lead Independent Director7.5yrsUS$348.28k0.056%
$ 2.6m
Wendy Yarno
Independent Director4.8yrsUS$320.78k0.017%
$ 794.5k
Deval Patrick
Independent Director2.4yrsUS$313.28k0.013%
$ 627.7k
Glenn Pierce
Independent Director6.7yrsUS$318.28k0.039%
$ 1.8m
Philip Pizzo
Independent Director7.1yrsUS$310.78k0.013%
$ 632.8k
Scott W. Morrison
Independent Director6.8yrsUS$333.28k0.0098%
$ 461.3k
Dawn Svoronos
Independent Director3.8yrsUS$316.36k0.0080%
$ 373.6k
Willie Brown
Advisor & Director Emeritusless than a yearUS$308.28k0.058%
$ 2.7m
Alexis Thompson
Independent Director1.6yrsUS$735.61k0.0049%
$ 229.7k

5.8yrs

평균 재임 기간

66yo

평균 연령

경험이 풍부한 이사회: G5B's board of directors are considered experienced (5.8 years average tenure).